Report cover image

Global Dry Age-Related Macular Degeneration Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 104 Pages
SKU # APRC20354280

Description

Summary

According to APO Research, The global Dry Age-Related Macular Degeneration market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Dry Age-Related Macular Degeneration is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Dry Age-Related Macular Degeneration is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Dry Age-Related Macular Degeneration is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global companies of Dry Age-Related Macular Degeneration include Santen Pharmaceuticals, Y2 Solution, Stealth Biotherapeutics, Phio Pharmaceuticals, Ocumension Therapeutics, Kubota Vision, Iveric Bio, Eyestem Research and Belite Bio, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Dry Age-Related Macular Degeneration, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dry Age-Related Macular Degeneration.

The Dry Age-Related Macular Degeneration market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Dry Age-Related Macular Degeneration market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Dry Age-Related Macular Degeneration Segment by Company

Santen Pharmaceuticals
Y2 Solution
Stealth Biotherapeutics
Phio Pharmaceuticals
Ocumension Therapeutics
Kubota Vision
Iveric Bio
Eyestem Research
Belite Bio
Bausch Health
Allergan
Alimera Science

Dry Age-Related Macular Degeneration Segment by Type

Oral
Injectables

Dry Age-Related Macular Degeneration Segment by Application

Above 40 Years
Above 60 Years
Above 75 Years

Dry Age-Related Macular Degeneration Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dry Age-Related Macular Degeneration market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Dry Age-Related Macular Degeneration and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dry Age-Related Macular Degeneration.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2020-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Dry Age-Related Macular Degeneration companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report

Table of Contents

104 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.3 Global Dry Age-Related Macular Degeneration Market Size Overview by Region 2020 VS 2024 VS 2031
1.4 Global Dry Age-Related Macular Degeneration Market Size by Region (2020-2031)
1.4.1 Global Dry Age-Related Macular Degeneration Market Size by Region (2020-2025)
1.4.2 Global Dry Age-Related Macular Degeneration Market Size by Region (2026-2031)
1.5 Key Regions Dry Age-Related Macular Degeneration Market Size (2020-2031)
1.5.1 North America Dry Age-Related Macular Degeneration Market Size Growth Rate (2020-2031)
1.5.2 Europe Dry Age-Related Macular Degeneration Market Size Growth Rate (2020-2031)
1.5.3 Asia-Pacific Dry Age-Related Macular Degeneration Market Size Growth Rate (2020-2031)
1.5.4 South America Dry Age-Related Macular Degeneration Market Size Growth Rate (2020-2031)
1.5.5 Middle East & Africa Dry Age-Related Macular Degeneration Market Size Growth Rate (2020-2031)
2 Dry Age-Related Macular Degeneration Market by Type
2.1 Type Introduction
2.1.1 Oral
2.1.2 Injectables
2.2 Global Dry Age-Related Macular Degeneration Market Size by Type
2.2.1 Global Dry Age-Related Macular Degeneration Market Size Overview by Type (2020-2031)
2.2.2 Global Dry Age-Related Macular Degeneration Historic Market Size Review by Type (2020-2025)
2.2.3 Global Dry Age-Related Macular Degeneration Market Size Forecasted by Type (2026-2031)
2.3 Global Dry Age-Related Macular Degeneration Market Size by Regions
2.3.1 North America Dry Age-Related Macular Degeneration Market Size Breakdown by Type (2020-2025)
2.3.2 Europe Dry Age-Related Macular Degeneration Market Size Breakdown by Type (2020-2025)
2.3.3 Asia-Pacific Dry Age-Related Macular Degeneration Market Size Breakdown by Type (2020-2025)
2.3.4 South America Dry Age-Related Macular Degeneration Market Size Breakdown by Type (2020-2025)
2.3.5 Middle East and Africa Dry Age-Related Macular Degeneration Market Size Breakdown by Type (2020-2025)
3 Dry Age-Related Macular Degeneration Market by Application
3.1 Type Introduction
3.1.1 Above 40 Years
3.1.2 Above 60 Years
3.1.3 Above 75 Years
3.2 Global Dry Age-Related Macular Degeneration Market Size by Application
3.2.1 Global Dry Age-Related Macular Degeneration Market Size Overview by Application (2020-2031)
3.2.2 Global Dry Age-Related Macular Degeneration Historic Market Size Review by Application (2020-2025)
3.2.3 Global Dry Age-Related Macular Degeneration Market Size Forecasted by Application (2026-2031)
3.3 Global Dry Age-Related Macular Degeneration Market Size by Regions
3.3.1 North America Dry Age-Related Macular Degeneration Market Size Breakdown by Application (2020-2025)
3.3.2 Europe Dry Age-Related Macular Degeneration Market Size Breakdown by Application (2020-2025)
3.3.3 Asia-Pacific Dry Age-Related Macular Degeneration Market Size Breakdown by Application (2020-2025)
3.3.4 South America Dry Age-Related Macular Degeneration Market Size Breakdown by Application (2020-2025)
3.3.5 Middle East and Africa Dry Age-Related Macular Degeneration Market Size Breakdown by Application (2020-2025)
4 Global Market Dynamics
4.1 Dry Age-Related Macular Degeneration Industry Trends
4.2 Dry Age-Related Macular Degeneration Industry Drivers
4.3 Dry Age-Related Macular Degeneration Industry Opportunities and Challenges
4.4 Dry Age-Related Macular Degeneration Industry Restraints
5 Competitive Insights by Company
5.1 Global Top Players by Dry Age-Related Macular Degeneration Revenue (2020-2025)
5.2 Global Dry Age-Related Macular Degeneration Industry Company Ranking, 2023 VS 2024 VS 2025
5.3 Global Dry Age-Related Macular Degeneration Key Company Headquarters & Area Served
5.4 Global Dry Age-Related Macular Degeneration Company, Product Type & Application
5.5 Global Dry Age-Related Macular Degeneration Company Commercialization Time
5.6 Market Competitive Analysis
5.6.1 Global Dry Age-Related Macular Degeneration Market CR5 and HHI
5.6.2 Global Top 5 and 10 Dry Age-Related Macular Degeneration Players Market Share by Revenue in 2024
5.6.3 2024 Dry Age-Related Macular Degeneration Tier 1, Tier 2, and Tier 3
6 Company Profiles
6.1 Santen Pharmaceuticals
6.1.1 Santen Pharmaceuticals Comapny Information
6.1.2 Santen Pharmaceuticals Business Overview
6.1.3 Santen Pharmaceuticals Dry Age-Related Macular Degeneration Revenue, Global Share and Gross Margin (2020-2025)
6.1.4 Santen Pharmaceuticals Dry Age-Related Macular Degeneration Product Portfolio
6.1.5 Santen Pharmaceuticals Recent Developments
6.2 Y2 Solution
6.2.1 Y2 Solution Comapny Information
6.2.2 Y2 Solution Business Overview
6.2.3 Y2 Solution Dry Age-Related Macular Degeneration Revenue, Global Share and Gross Margin (2020-2025)
6.2.4 Y2 Solution Dry Age-Related Macular Degeneration Product Portfolio
6.2.5 Y2 Solution Recent Developments
6.3 Stealth Biotherapeutics
6.3.1 Stealth Biotherapeutics Comapny Information
6.3.2 Stealth Biotherapeutics Business Overview
6.3.3 Stealth Biotherapeutics Dry Age-Related Macular Degeneration Revenue, Global Share and Gross Margin (2020-2025)
6.3.4 Stealth Biotherapeutics Dry Age-Related Macular Degeneration Product Portfolio
6.3.5 Stealth Biotherapeutics Recent Developments
6.4 Phio Pharmaceuticals
6.4.1 Phio Pharmaceuticals Comapny Information
6.4.2 Phio Pharmaceuticals Business Overview
6.4.3 Phio Pharmaceuticals Dry Age-Related Macular Degeneration Revenue, Global Share and Gross Margin (2020-2025)
6.4.4 Phio Pharmaceuticals Dry Age-Related Macular Degeneration Product Portfolio
6.4.5 Phio Pharmaceuticals Recent Developments
6.5 Ocumension Therapeutics
6.5.1 Ocumension Therapeutics Comapny Information
6.5.2 Ocumension Therapeutics Business Overview
6.5.3 Ocumension Therapeutics Dry Age-Related Macular Degeneration Revenue, Global Share and Gross Margin (2020-2025)
6.5.4 Ocumension Therapeutics Dry Age-Related Macular Degeneration Product Portfolio
6.5.5 Ocumension Therapeutics Recent Developments
6.6 Kubota Vision
6.6.1 Kubota Vision Comapny Information
6.6.2 Kubota Vision Business Overview
6.6.3 Kubota Vision Dry Age-Related Macular Degeneration Revenue, Global Share and Gross Margin (2020-2025)
6.6.4 Kubota Vision Dry Age-Related Macular Degeneration Product Portfolio
6.6.5 Kubota Vision Recent Developments
6.7 Iveric Bio
6.7.1 Iveric Bio Comapny Information
6.7.2 Iveric Bio Business Overview
6.7.3 Iveric Bio Dry Age-Related Macular Degeneration Revenue, Global Share and Gross Margin (2020-2025)
6.7.4 Iveric Bio Dry Age-Related Macular Degeneration Product Portfolio
6.7.5 Iveric Bio Recent Developments
6.8 Eyestem Research
6.8.1 Eyestem Research Comapny Information
6.8.2 Eyestem Research Business Overview
6.8.3 Eyestem Research Dry Age-Related Macular Degeneration Revenue, Global Share and Gross Margin (2020-2025)
6.8.4 Eyestem Research Dry Age-Related Macular Degeneration Product Portfolio
6.8.5 Eyestem Research Recent Developments
6.9 Belite Bio
6.9.1 Belite Bio Comapny Information
6.9.2 Belite Bio Business Overview
6.9.3 Belite Bio Dry Age-Related Macular Degeneration Revenue, Global Share and Gross Margin (2020-2025)
6.9.4 Belite Bio Dry Age-Related Macular Degeneration Product Portfolio
6.9.5 Belite Bio Recent Developments
6.10 Bausch Health
6.10.1 Bausch Health Comapny Information
6.10.2 Bausch Health Business Overview
6.10.3 Bausch Health Dry Age-Related Macular Degeneration Revenue, Global Share and Gross Margin (2020-2025)
6.10.4 Bausch Health Dry Age-Related Macular Degeneration Product Portfolio
6.10.5 Bausch Health Recent Developments
6.11 Allergan
6.11.1 Allergan Comapny Information
6.11.2 Allergan Business Overview
6.11.3 Allergan Dry Age-Related Macular Degeneration Revenue, Global Share and Gross Margin (2020-2025)
6.11.4 Allergan Dry Age-Related Macular Degeneration Product Portfolio
6.11.5 Allergan Recent Developments
6.12 Alimera Science
6.12.1 Alimera Science Comapny Information
6.12.2 Alimera Science Business Overview
6.12.3 Alimera Science Dry Age-Related Macular Degeneration Revenue, Global Share and Gross Margin (2020-2025)
6.12.4 Alimera Science Dry Age-Related Macular Degeneration Product Portfolio
6.12.5 Alimera Science Recent Developments
7 North America
7.1 North America Dry Age-Related Macular Degeneration Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2 North America Dry Age-Related Macular Degeneration Market Size by Country (2020-2025)
7.3 North America Dry Age-Related Macular Degeneration Market Size Forecast by Country (2026-2031)
8 Europe
8.1 Europe Dry Age-Related Macular Degeneration Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2 Europe Dry Age-Related Macular Degeneration Market Size by Country (2020-2025)
8.3 Europe Dry Age-Related Macular Degeneration Market Size Forecast by Country (2026-2031)
9 Asia-Pacific
9.1 Asia-Pacific Dry Age-Related Macular Degeneration Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2 Asia-Pacific Dry Age-Related Macular Degeneration Market Size by Country (2020-2025)
9.3 Asia-Pacific Dry Age-Related Macular Degeneration Market Size Forecast by Country (2026-2031)
10 South America
10.1 South America Dry Age-Related Macular Degeneration Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2 South America Dry Age-Related Macular Degeneration Market Size by Country (2020-2025)
10.3 South America Dry Age-Related Macular Degeneration Market Size Forecast by Country (2026-2031)
11 Middle East & Africa
11.1 Middle East & Africa Dry Age-Related Macular Degeneration Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2 Middle East & Africa Dry Age-Related Macular Degeneration Market Size by Country (2020-2025)
11.3 Middle East & Africa Dry Age-Related Macular Degeneration Market Size Forecast by Country (2026-2031)
12 Concluding Insights
13 Appendix
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.